Administration of Diphenhydramine

Introduction to Diphenhydramine Administration

The American Academy of Allergy, Asthma, and Immunology recommends diphenhydramine for anaphylaxis management, as part of treatment protocol alongside epinephrine, with a dosage of 25-50 mg (1-2 mg/kg) 1, 2
Diphenhydramine is particularly useful in anaphylaxis management, as part of treatment protocol alongside epinephrine, with a recommended standard dose of 1-2 mg/kg or 25-50 mg per dose for acute allergic reactions/anaphylaxis, often used in combination with H2 antihistamines like ranitidine for superior effect 1, 2

For allergic reactions/anaphylaxis, the recommended dosage is 25-50 mg (1-2 mg/kg) 1, 2
The American Heart Association suggests a dose of 1 mg/kg when used as premedication for thymoglobulin administration 3
The American Academy of Pediatrics recommends a dose of 1-2 mg/kg (maximum initial dose: 50 mg) for the treatment of dystonic reactions 4
The administration rate of IV diphenhydramine should not exceed 25 mg/minute to minimize adverse effects, such as respiratory depression, especially when combined with other sedatives 4

Monitor for sedation and respiratory depression, especially when combined with other sedatives, in patients receiving diphenhydramine 1, 4
Consider cardiac monitoring in patients with heart disease due to potential QT interval prolongation 1
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration
Sedation and cognitive impairment are common adverse effects of IV diphenhydramine, and may cause respiratory depression, especially when combined with other sedatives 4
Rapid IV administration may precipitate seizures, and can cause paradoxical excitation or agitation 4
Exceeding the recommended administration rate, combining with other sedatives without appropriate monitoring, prolonged use of high doses, and failure to adjust dosing in elderly patients or those with hepatic impairment are all contraindications for IV diphenhydramine use 4
Newer second-generation antihistamines, such as IV cetirizine, may be preferable in some situations due to less sedation, fewer adverse events, shorter time spent in treatment centers, and lower rates of return visits to treatment centers